-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on Amgen, Raises Price Target to $460

Benzinga·08/19/2026 13:17:15
语音播报
Argus Research analyst Jasper Hellweg maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $375 to $460.